Correlation Between Platinum Investment and BioNTech

Can any of the company-specific risk be diversified away by investing in both Platinum Investment and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Platinum Investment and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Platinum Investment Management and BioNTech SE, you can compare the effects of market volatilities on Platinum Investment and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Platinum Investment with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Platinum Investment and BioNTech.

Diversification Opportunities for Platinum Investment and BioNTech

-0.22

Correlation Coefficient

Platinum Investment  BioNTech

Very good diversification

The 3 months correlation between Platinum and BioNTech is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Platinum Investment Management and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Platinum Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Platinum Investment Management are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Platinum Investment i.e., Platinum Investment and BioNTech go up and down completely randomly.

Pair Corralation between Platinum Investment and BioNTech

Assuming the 90 days horizon Platinum Investment Management is expected to generate 1.37 times more return on investment than BioNTech. However, Platinum Investment is 1.37 times more volatile than BioNTech SE. It trades about 0.07 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.03 per unit of risk. If you would invest  30.00  in Platinum Investment Management on April 24, 2025 and sell it today you would earn a total of  4.00  from holding Platinum Investment Management or generate 13.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Platinum Investment Management  vs.  BioNTech SE

Platinum Investment

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Platinum Investment Management are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Platinum Investment reported solid returns over the last few months and may actually be approaching a breakup point.

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BioNTech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Platinum Investment and BioNTech

The main advantage of trading using opposite Platinum Investment and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Platinum Investment position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Platinum Investment Management and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.